// App-Quantinova.ai

e18045 : Role of ERBB receptor feedback inhibitor 1 (ERRFI1) downregulation in progression of premalignant oral lesions to cancer.

Researchers

Presenter

  • Prajwal A

Principal Investigators

  • Anurag Kumar

  • Shyam Chauhan

Medical Centers

  • All India Institute of Medical Sciences, New Delhi, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Dental and Oral Health

Disease

  • N/A

Biomarkers

  • Epidermal growth factor receptor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final